Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

DRE and LUTS

Principal Investigator
Name
Jonathan Shoag
Institution
NA
Position Title
Resident physician
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-177
Initial CDAS Request Approval
Nov 6, 2015
Title
DRE and LUTS
Summary
Though the digital rectal exam (DRE) is a key component of prostate cancer screening, its utility in the workup of lower urinary tract symptoms is poorly understood. Nocturia is among the most bothersome lower urinary tract symptoms, and its multifactorial etiology requires broad clinical evaluation. Using data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, this study aims to assess the accuracy and reliability of DRE in estimating prostate size and to correlate these findings to the presence of nocturia.
Aims

1. To assess the accuracy and reliability of DRE in estimating prostate size
2. To correlate these findings to the presence of nocturia.

Related Publications